Second cancer risk after diagnostic and monitoring radiation exposure with computed tomography in patients with hepatocellular carcinoma.
Joong‐Won Park(National Cancer Center), Young Hwan Koh(National Cancer Center), Moran Ki(National Cancer Center), Hyunsoon Cho(National Cancer Center), Ju‐Hee Lee(Dongguk University), Hwa Young Choi(National Cancer Center)
Cited by 1
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775